Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Oxford based Founder operating in the Genetics space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation โ Operating as a key part in an extremely innovative business or startup.
- Growth โ Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management โ Showing exceptional management skills.
- Societal impact โ Putting their business on the map for their positive societal or environmental impact.
Our Data โ We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Prof James Davies
Co-Founder of Nucleome Therapeutics
James Davies is the Co-Founder of Nucleome Therapeutics.
Follow Prof James Davies:
About Nucleome Therapeutics: Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Prof James Davies
Co-Founder of Nucleome Therapeutics
James Davies is the Co-Founder of Nucleome Therapeutics.
Follow Prof James Davies:
About Nucleome Therapeutics: Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Prof Jim Hughes
Co-Founder of Nucleome Therapeutics
Jim Hughes is the Co-Founder of Nucleome Therapeutics and a Professor of Gene Regulation at the University of Oxford.
Follow Prof Jim Hughes:
About Nucleome Therapeutics: Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Prof Jim Hughes
Co-Founder of Nucleome Therapeutics
Jim Hughes is the Co-Founder of Nucleome Therapeutics and a Professor of Gene Regulation at the University of Oxford.
Follow Prof Jim Hughes:
About Nucleome Therapeutics: Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Dr. Danuta Jeziorska
CEO & Co-Founder of Nucleome Therapeutics
Danuta Jeziorska is the CEO & Co-Founder at Nucleome Therapeutics.
Follow Dr. Danuta Jeziorska:
About Nucleome Therapeutics: Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Dr. Danuta Jeziorska
CEO & Co-Founder of Nucleome Therapeutics
Danuta Jeziorska is the CEO & Co-Founder at Nucleome Therapeutics.
Follow Dr. Danuta Jeziorska:
About Nucleome Therapeutics: Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
George Busby
CSO and Co-Founder of Allelica
George is a geneticist and a writer. He has been a researcher at the University of Oxford for more than 5 years and his scientific work has been published in Nature and Science. He was always fascinated by the possibility of using the information contained in our DNA to reconstruct the evolutionary history of human beings. He now leads the Allelica scientific team, bringing the predictive genomic accuracy of the Polygenic approach to the market for the first time.
Follow George Busby:
About Allelica: Allelica is a genomics software company driving the transition of Polygenic Risk Score from Genomic research to clinical application.
Roland Bonney
Co-Founder of Benchmark Holdings
Follow Roland Bonney:
About Benchmark Holdings: Benchmark Holdings, a pioneering bioagtech company.
Lukas Lange
CEO and Co-Founder of Probably Genetic
Follow Lukas Lange:
About Probably Genetic: Probably Genetic helps rare genetic disease patients.
Chris Spencer
Co-Founder and Head of Innovation of Genomics
Chris Spencer is Founder of Genomics PLC and serves as its Director. Chris Spencerโs collect, curate, analyse and interpret very large amounts of genetic data to help understand human diseases. His career has happily coincided with an era of collaboration it made major inroads into understanding of human genetics. He has played a lead analytical role in the International HapMap project and the Wellcome Trust Cases Controls Consortium. As a young scientist, his early work in large scale human data was awarded the Corcoran Memorial Prize from the Department of Statistics at the University of Oxford, which is awarded every two years for outstanding graduate work. His works are Cell-Mediated Immune Mechanisms, Visceral Leishmaniasis and Large Vessel Ischemic Stroke.
Follow Chris Spencer:
About Genomics: Genomics plc aiming to lead the genomic transformation of healthcare.
Gil McVean
Co Founder & Director of Genomics
Gil McVean is Professor of Statistical Genetics at the University of Oxford and Head of Bioinformatics and Statistical Genetics at the Wellcome Trust Centre for Human Genetics. After an undergraduate training in Zoology, he obtained a PhD with Laurence Hurst in Cambridge and worked with Brian and Deborah Charlesworth in Edinburgh before joining Oxford in 2000. His research focuses on understanding the molecular and evolutionary processes that shape genetic variation in populations and the relationship between genetic variation and phenotype. He has made contributions to our understanding of areas including recombination hotspots, historical patterns of natural selection, the male mutation rate, human genetic variation, the role of HLA in complex disease and genealogical processes. He has played a leading role in the HapMap and 1000 Genomes Projects and currently works on organisms from HIV to malaria.
Follow Gil McVean:
About Genomics: Genomics plc aiming to lead the genomic transformation of healthcare.
Stuart Grice
Co-Founder and CSO of FitnessGenes
Stuart is a co-founder of FitnessGenes, and also a published scientist who adds current and cutting edge expertise to the science team. After a short plunge into the world of finance, he decided scientific enlightenment was where itโs at. Having studied subjects as diverse as neuromuscular disorders and autism, he continues to work on understanding how the variations in both genetics and metabolism impact on human health.
Follow Stuart Grice:
About FitnessGenes: FitnessGenes is pioneering the field of genetic data analysis to produce personalized fitness and diet recommendations.
Samantha Decombel
Co-Founder & CEO of FitnessGenes
A co-founder of FitnessGenes, with a PhD in genetics and a passion for science communication, Sam is responsible for product development and management of the science team. Fascinated by genetics from an early age, she studied the subject for her PhD at the University of Birmingham, UK, where she has also lectured on Evolutionary and Conservation Genetics. Sam is an enthusiastic sportswoman, and particularly enjoys playing football and running when she is not in the gym trying to improve on her squat PB of 165lb.
Follow Samantha Decombel:
About FitnessGenes, InnovationXchange, Play DNA: FitnessGenes is pioneering the field of genetic data analysis to produce personalized fitness and diet recommendations.
